{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:29:53Z","timestamp":1790983793712,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,30]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Metabolic dysfunction and dysregulation of leptin signaling have been linked to Alzheimer\u2019s disease (AD)\u2019s pathophysiology. The objectives of this study were to examine the associations between plasma leptin, cerebrospinal fluid (CSF), beta-amyloid (A\u03b2), and tau biomarkers (AT[N] status) and with the stage of cognitive impairment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Cross-sectional analysis of data from cognitively impaired patients from a tertiary memory clinic. Plasma leptin levels were compared according to the stage of cognitive impairment and biomarker profiles, using the AT(N) classification. Linear regression models were performed to examine the relationship between leptin and CSF biomarkers. Results were adjusted for age, gender, body mass index (BMI), and APOE \u03b54. In a subgroup of A+T+ individuals, we compared the 2-year evolution of Mini-Mental State Examination scores, according to the participants\u2019 tertile of plasma leptin levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 1 036 participants (age 68.7 \u00b1 9.1, females = 54.1%). A+T+ and A+T\u2212 patients had significantly lower plasma leptin levels than amyloid negative participants (p &amp;lt; .01). CSF A\u03b2 concentration was significantly associated with lower plasma leptin \u03b2 = \u22124.3 (1.5), p = .005 unadjusted; and \u03b2 = \u22123.4 (1.6), p = .03 after adjustment for age, female gender, BMI, and APOE \u03b54. Patients with major neurocognitive disorder due to AD had a difference of leptin of \u22127.3 ng\/mL 95% confidence interval (CI; \u221211.8; \u22122.8), p = .0002, compared to individuals with other causes of cognitive impairment. Leptin was not associated with the slope of cognitive decline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Plasma leptin levels were associated with CSF A\u03b2 and with the diagnosis of AD confirmed by CSF biomarkers, suggesting a molecular interplay between leptin metabolism and brain amyloid deposition.<\/jats:p><\/jats:sec>","DOI":"10.1093\/gerona\/glac234","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T15:27:31Z","timestamp":1669649251000},"page":"645-652","source":"Crossref","is-referenced-by-count":29,"title":["Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer\u2019s Disease Diagnosis in Cognitively Impaired Patients"],"prefix":"10.1093","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-2413","authenticated-orcid":false,"given":"Matthieu","family":"Lilamand","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, INSERM Unit UMR S-1144 , Paris , France"},{"name":"Department of Geriatrics, Lariboisi\u00e8re-Fernand Widal Hospital GHU AP-HP.Nord , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Bouaziz-Amar","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, INSERM Unit UMR S-1144 , Paris , France"},{"name":"Biochemistry Department, Lariboisi\u00e8re Hospital GHU AP-HP.Nord , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Dumurgier","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, INSERM Unit UMR S-1144 , Paris , France"},{"name":"Cognitive Neurology Center, Lariboisi\u00e8re-Fernand Widal Hospital GHU AP-HP.Nord , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3521-5832","authenticated-orcid":false,"given":"Emmanuel","family":"Cognat","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, INSERM Unit UMR S-1144 , Paris , France"},{"name":"Cognitive Neurology Center, Lariboisi\u00e8re-Fernand Widal Hospital GHU AP-HP.Nord , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hourregue","sequence":"additional","affiliation":[{"name":"Cognitive Neurology Center, Lariboisi\u00e8re-Fernand Widal Hospital GHU AP-HP.Nord , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Mouton-Liger","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, INSERM Unit UMR S-1144 , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4486-7928","authenticated-orcid":false,"given":"Manuel","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, INSERM Unit UMR S-1144 , Paris , France"},{"name":"Department of Geriatrics, Bichat GHU AP-HP.Nord , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-C\u00e9cile","family":"Troussi\u00e8re","sequence":"additional","affiliation":[{"name":"Neurologist, 23 Esp. du Grand Si\u00e8cle , Versailles , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Martinet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, INSERM Unit UMR S-1144 , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Hugon","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, INSERM Unit UMR S-1144 , Paris , France"},{"name":"Cognitive Neurology Center, Lariboisi\u00e8re-Fernand Widal Hospital GHU AP-HP.Nord , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Paquet","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, INSERM Unit UMR S-1144 , Paris , France"},{"name":"Cognitive Neurology Center, Lariboisi\u00e8re-Fernand Widal Hospital GHU AP-HP.Nord , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"issue":"4","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"10284","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet."},{"key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fnagi.2018.00312","article-title":"Inflammation: bridging age, menopause and APOE\u03b54 genotype to Alzheimer\u2019s disease","volume":"10","author":"Mishra","year":"2018","journal-title":"Front Aging Neurosci."},{"key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3389\/fnins.2018.00830","article-title":"Insulin resistance in Alzheimer\u2019s disease","volume":"12","author":"Ferreira","year":"2018","journal-title":"Front Neurosci."},{"issue":"1","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jnc.12380","article-title":"Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance","volume":"128","author":"Bonda","year":"2014","journal-title":"J Neurochem."},{"issue":"6","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopsych.2009.02.013","article-title":"Meta-analysis of Alzheimer\u2019s disease risk with obesity, diabetes, and related disorders","volume":"67","author":"Profenno","year":"2010","journal-title":"Biol Psychiatry."},{"issue":"1","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-14-0405","article-title":"20 years of leptin: leptin at 20: an overview","volume":"223","author":"Friedman","year":"2014","journal-title":"J Endocrinol."},{"key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.physiol.70.113006.100707","article-title":"Mechanisms of leptin action and leptin resistance","volume":"70","author":"Myers","year":"2008","journal-title":"Annu Rev Physiol."},{"issue":"1","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1523\/JNEUROSCI.18-01-00559.1998","article-title":"Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus","volume":"18","author":"H\u00e2kansson","year":"1998","journal-title":"J Neurosci."},{"issue":"6","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.coph.2007.10.006","article-title":"Leptin regulation of neuronal excitability and cognitive function","volume":"7","author":"Harvey","year":"2007","journal-title":"Curr Opin Pharmacol."},{"issue":"suppl 1","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2009.02735.x","article-title":"The role of nutrition in Alzheimer\u2019s disease: epidemiological evidence","volume":"16","author":"Morris","year":"2009","journal-title":"Eur J Neurol."},{"issue":"3","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3233\/JAD-2011-110713","article-title":"Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer\u2019s disease","volume":"28","author":"Soto","year":"2012","journal-title":"J Alzheimers Dis."},{"issue":"3","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3233\/JAD-141086","article-title":"2003\u20132013: a decade of body mass index, Alzheimer\u2019s disease, and dementia","volume":"43","author":"Emmerzaal","year":"2015","journal-title":"J Alzheimers Dis."},{"issue":"2","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10571-015-0282-7","article-title":"Leptin dysfunction and Alzheimer\u2019s disease: evidence from cellular, animal, and human studies","volume":"36","author":"McGuire","year":"2016","journal-title":"Cell Mol Neurobiol."},{"issue":"9","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.bbadis.2014.05.015","article-title":"Leptin attenuates BACE1 expression and amyloid-\u03b2 genesis via the activation of SIRT1 signaling pathway","volume":"1842","author":"Marwarha","year":"2014","journal-title":"Biochim Biophys Acta."},{"issue":"2","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-140006","article-title":"Altered serum levels of adipokines and insulin in probable Alzheimer\u2019s disease","volume":"41","author":"Khemka","year":"2014","journal-title":"J Alzheimers Dis."},{"key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.npep.2015.05.006","article-title":"Plasma leptin levels and free leptin index in women with Alzheimer\u2019s disease","volume":"52","author":"Baranowska-Bik","year":"2015","journal-title":"Neuropeptides"},{"issue":"3","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3233\/JAD-180533","article-title":"Association between peripheral leptin and adiponectin levels and cognitive decline in patients with neurocognitive disorders \u226565 years","volume":"66","author":"Gilbert","year":"2018","journal-title":"J Alzheimers Dis."},{"issue":"9","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"M935","DOI":"10.1093\/gerona\/59.9.M935","article-title":"Adipocytokines, fat distribution, and insulin resistance in elderly men and women","volume":"59","author":"Zoico","year":"2004","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"2023033020105234700_","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association.","year":"2013"},{"issue":"3","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement J Alzheimers Assoc."},{"issue":"3","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state.\u201d A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res."},{"issue":"16","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"e1648","DOI":"10.1212\/WNL.0000000000200110","article-title":"Autopsy validation of the diagnostic accuracy of 123I-metaiodobenzylguanidine myocardial scintigraphy for Lewy body disease","volume":"98","author":"Matsubara","year":"2022","journal-title":"Neurology"},{"issue":"23","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1001\/jama.2009.1836","article-title":"Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging","volume":"302","author":"Lieb","year":"2009","journal-title":"JAMA"},{"issue":"6","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/gerona\/glab267","article-title":"Adiponectin, leptin, and resistin and the risk of dementia","volume":"77","author":"Mooldijk","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"1","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3233\/JAD-170983","article-title":"Effects of gender and other confounding factors on leptin concentrations in Alzheimer\u2019s disease: evidence from the combined analysis of 27 case-control studies","volume":"62","author":"Zhou","year":"2018","journal-title":"J Alzheimers Dis."},{"issue":"11","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/ph13110401","article-title":"Altered brain leptin and leptin receptor expression in the 5XFAD mouse model of Alzheimer\u2019s disease","volume":"13","author":"Pratap","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"2023033020105234700_","first-page":"1","article-title":"Disruption of leptin signaling in a mouse model of Alzheimer\u2019s disease","volume":"2","author":"King","year":"2018","journal-title":"Metab Brain Dis."},{"issue":"5054","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbrc.2009.01.041","article-title":"Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells","volume":"380","author":"Greco","year":"2009","journal-title":"Biochem Biophys Res Commun."},{"key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbadis.2012.12.009","article-title":"Leptin regulates amyloid production via the \u03b3-secretase complex","volume":"1832","author":"Niedowicz","year":"2013","journal-title":"Biochim Biophys Acta."},{"issue":"4","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000508105","article-title":"Amyloid beta peptide is an endogenous negative allosteric modulator of leptin receptor","volume":"111","author":"Cecon","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"1","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000442616","article-title":"Leptin regulates tau phosphorylation through Wnt signaling pathway in PC12 cells","volume":"24","author":"Zhang","year":"2016","journal-title":"Neurosignals"},{"issue":"12","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/abbs\/gmv106","article-title":"Leptin signaling plays a critical role in the geniposide-induced decrease of tau phosphorylation","volume":"47","author":"Liu","year":"2015","journal-title":"Acta Biochim Biophys Sin (Shanghai)."},{"issue":"4","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3233\/JAD-2010-1308","article-title":"Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer\u2019s disease","volume":"19","author":"Greco","year":"2010","journal-title":"J Alzheimers Dis."},{"key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"848180","DOI":"10.3389\/fnagi.2022.848180","article-title":"Microglial activation, tau pathology, and neurodegeneration biomarkers predict longitudinal cognitive decline in Alzheimer\u2019s disease continuum","volume":"14","author":"Chen","year":"2022","journal-title":"Front Aging Neurosci."},{"issue":"1","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/ageing\/afu160","article-title":"Plasma leptin levels are not predictive of dementia in patients with mild cognitive impairment","volume":"44","author":"Oania","year":"2015","journal-title":"Age Ageing."},{"issue":"3","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3233\/JAD-191247","article-title":"Association between leptin, cognition, and structural brain measures among \u201cearly\u201d middle-aged adults: results from the Framingham Heart Study third generation cohort","volume":"77","author":"Sanborn","year":"2020","journal-title":"J Alzheimers Dis."},{"issue":"9","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.neurobiolaging.2007.11.024","article-title":"Serum leptin level and cognition in the elderly: findings from the Health ABC Study","volume":"30","author":"Holden","year":"2009","journal-title":"Neurobiol Aging."},{"issue":"12","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/alz.12157","article-title":"Vascular contributions to cognitive impairment and dementia (VCID): a report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop","volume":"16","author":"Zlokovic","year":"2020","journal-title":"Alzheimers Dement."},{"key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"105219","DOI":"10.1016\/j.nbd.2020.105219","article-title":"Leptin enhances adult neurogenesis and reduces pathological features in a transgenic mouse model of Alzheimer\u2019s disease","volume":"148","author":"Cali\u00f3","year":"2021","journal-title":"Neurobiol Dis."},{"issue":"4","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3233\/JAD-2009-1021","article-title":"Leptin: a novel therapeutic strategy for Alzheimer\u2019s disease","volume":"16","author":"Tezapsidis","year":"2009","journal-title":"J Alzheimers Dis."},{"issue":"2","key":"2023033020105234700_","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1567205010666131212114156","article-title":"Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential","volume":"11","author":"Johnston","year":"2014","journal-title":"Curr Alzheimer Res."}],"container-title":["The Journals of Gerontology: Series A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/advance-article-pdf\/doi\/10.1093\/gerona\/glac234\/48771408\/glac234.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/78\/4\/645\/49701585\/glac234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/78\/4\/645\/49701585\/glac234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T16:52:57Z","timestamp":1701449577000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article\/78\/4\/645\/6849578"}},"subtitle":[],"editor":[{"given":"Jay","family":"Magaziner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,11,28]]},"published-print":{"date-parts":[[2023,3,30]]}},"URL":"https:\/\/doi.org\/10.1093\/gerona\/glac234","relation":{},"ISSN":["1079-5006","1758-535X"],"issn-type":[{"value":"1079-5006","type":"print"},{"value":"1758-535X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2022,11,28]]}}}